FDC Limited (NSE:FDC)

Market Cap	78.95B
Revenue (ttm)	21.18B
Net Income (ttm)	2.69B
Shares Out	n/a
EPS (ttm)	16.53
PE Ratio	29.34
Forward PE	n/a
Dividend	5.00 (1.05%)
Ex-Dividend Date	Nov 22, 2024

Volume	55,950
Average Volume	96,537
Open	484.80
Previous Close	484.80
Day's Range	480.85 - 487.05
52-Week Range	366.25 - 658.85
Beta	-0.06
RSI	52.00
Earnings Date	Aug 6, 2025

About FDC Limited

FDC Limited manufactures and markets pharmaceutical products in India and internationally. The company offers specialized formulations for various therapeutic segments, including anti-infective, gastrointestinal, ophthalmic, vitamins, minerals, dietary supplements, cardiac, anti-diabetes, respiratory, gynaecology, dermatology, and analgesics; and anti-oxidants, balanced energy and protein drinks, and vitamins and nutraceuticals, as well as various active pharmaceutical ingredients. It provides its products under the Zifi, Zefu, Zocon, Amodep-AT...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1936
• Employees: 6,659
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: FDC

Financial Performance

In 2024, FDC Limited's revenue was 21.08 billion, an increase of 8.50% compared to the previous year's 19.43 billion. Earnings were 2.67 billion, a decrease of -12.59%.